189 related articles for article (PubMed ID: 15859549)
1. [Antioxidant status of patients with primary colorectal cancer and liver metastases of colorectal cancer].
Czeczot H; Skrzycki M; Podsiad M; Gawryszewska E; Nyckowski P; Porembska Z
Pol Merkur Lekarski; 2005 Jan; 18(103):58-61. PubMed ID: 15859549
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of antioxidant status in patients with primary hepatocellular carcinoma].
Czeczot H; Skrzycki M; Gawryszewska E; Podsiad M; Porembska Z
Pol Merkur Lekarski; 2003 Aug; 15(86):118-22. PubMed ID: 14648972
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant potential in esophageal, stomach and colorectal cancers.
Skrzydlewska E; Kozuszko B; Sulkowska M; Bogdan Z; Kozlowski M; Snarska J; Puchalski Z; Sulkowski S; Skrzydlewski Z
Hepatogastroenterology; 2003; 50(49):126-31. PubMed ID: 12630007
[TBL] [Abstract][Full Text] [Related]
4. Effect of Cu(II) coordination compounds on the activity of antioxidant enzymes catalase and superoxide dismutase in patients with colorectal cancer.
Kubiak K; Malinowska K; Langer E; Dziki Ł; Dziki A; Majsterek I
Pol Przegl Chir; 2011 Mar; 83(3):155-60. PubMed ID: 22166318
[TBL] [Abstract][Full Text] [Related]
5. The activity of antioxidant enzymes in colorectal adenocarcinoma and corresponding normal mucosa.
Strzelczyk JK; Wielkoszyński T; Krakowczyk Ł; Adamek B; Zalewska-Ziob M; Gawron K; Kasperczyk J; Wiczkowski A
Acta Biochim Pol; 2012; 59(4):549-56. PubMed ID: 23189274
[TBL] [Abstract][Full Text] [Related]
6. Lipid peroxidation and antioxidant status in stomach cancer.
Batcioglu K; Mehmet N; Ozturk IC; Yilmaz M; Aydogdu N; Erguvan R; Uyumlu B; Genc M; Karagozler AA
Cancer Invest; 2006 Feb; 24(1):18-21. PubMed ID: 16466987
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress with altered element content and decreased ATP level of erythrocytes in hepatocellular carcinoma and colorectal liver metastases.
Váli L; Hahn O; Kupcsulik P; Drahos A; Sárváry E; Szentmihályi K; Pallai Z; Kurucz T; Sípos P; Blázovics A
Eur J Gastroenterol Hepatol; 2008 May; 20(5):393-8. PubMed ID: 18403940
[TBL] [Abstract][Full Text] [Related]
8. Total antioxidant status value and superoxide dismutase activity in human colorectal cancer tissue depending on the stage of the disease: a pilot study.
Kocot J; Kiełczykowska M; Dąbrowski W; Piłat J; Rudzki S; Musik I
Adv Clin Exp Med; 2013; 22(3):431-7. PubMed ID: 23828685
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer.
Noike T; Miwa S; Soeda J; Kobayashi A; Miyagawa S
Hum Pathol; 2008 Feb; 39(2):201-8. PubMed ID: 17949784
[TBL] [Abstract][Full Text] [Related]
10. [Arginase as a marker of cancerogenesis. I. Monitoring patients after resection of colorectal cancer].
Porembska Z; Mielczarek M; Nyckowski P; Barańczyk-Kuźma A
Pol Merkur Lekarski; 2002 Oct; 13(76):284-5. PubMed ID: 12557431
[TBL] [Abstract][Full Text] [Related]
11. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.
Kharrazi H; Vaisi-Raygani A; Rahimi Z; Tavilani H; Aminian M; Pourmotabbed T
Clin Biochem; 2008 Aug; 41(12):932-6. PubMed ID: 18505684
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
13. Serum arginase activity in postsurgical monitoring of patients with colorectal carcinoma.
Porembska Z; Skwarek A; Mielczarek M; Barańczyk-Kuźma A
Cancer; 2002 Jun; 94(11):2930-4. PubMed ID: 12115381
[TBL] [Abstract][Full Text] [Related]
14. Influence of therapy on the antioxidant status in patients with melanoma.
Gadjeva V; Dimov A; Georgieva N
J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
[TBL] [Abstract][Full Text] [Related]
15. [Arginase a marker of cancerogenesis. II. Monitoring of patients after resection of colorectal liver metastases].
Porembska Z; Nyckowski P; Skwarek A; Mielczarek M; Barańczyk-Kuźma A
Pol Merkur Lekarski; 2002 Oct; 13(76):286-8. PubMed ID: 12557432
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significances of oxidative DNA damage evaluated by 8-hydroxy-deoxyguanosine and antioxidant enzymes in patients undergoing resection of gastric and colon carcinoma.
Dincer Y; Himmetoglu S; Akcay T; Ersoy EY; Gunes KN; Tortum O
Neoplasma; 2007; 54(2):131-6. PubMed ID: 17319786
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
[TBL] [Abstract][Full Text] [Related]
18. [A comparative study of free radical-assisted processes and antioxidant protection of certain areas of liver involvement].
Shalashnaia EV; Nepomniashchaia EM; Goroshinskaia IA; Nemashkalova LA; Gusarev SA
Vopr Onkol; 2007; 53(1):46-8. PubMed ID: 17649733
[TBL] [Abstract][Full Text] [Related]
19. L-arginine as a factor increasing arginase significance in diagnosis of primary and metastatic colorectal cancer.
Graboń W; Mielczarek-Puta M; Chrzanowska A; Barańczyk-Kuźma A
Clin Biochem; 2009 Mar; 42(4-5):353-7. PubMed ID: 19101531
[TBL] [Abstract][Full Text] [Related]
20. Increased antioxidant enzyme activities in the colorectal adenoma and carcinoma.
Beno I; Staruchová M; Volkovová K; Bátovský M
Neoplasma; 1995; 42(5):265-9. PubMed ID: 8552207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
